<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03178006</url>
  </required_header>
  <id_info>
    <org_study_id>419.676</org_study_id>
    <nct_id>NCT03178006</nct_id>
  </id_info>
  <brief_title>Correlation Between Intestinal Microbiota, Inflamatory Biomarkers, Intestinal Morphology, Hepatic Fibrosis Degree and Vascular Reactivity.</brief_title>
  <official_title>Correlation Between Intestinal Microbiota, Inflamatory Biomarkers, Intestinal Morphology, Hepatic Fibrosis Degree and Vascular Reactivity in Patients With Different Degrees of Glucose Tolerance and Body Adiposity.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rio de Janeiro State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rio de Janeiro State University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project aims to establish the correlation between intestinal microbiota with&#xD;
      inflammatory biomarkers, intestinal morphology, vascular reactivity and degree of hepatic&#xD;
      fibrosis in patients with different degrees of glucose tolerance and body adiposity.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obese patients with dysglycemia or not, from the Obesity Outpatient Clinic, and individuals&#xD;
      with normal or overweight weight with dysglycemia or not, preferably from the same social&#xD;
      class and type of diet of the obese will be invited to participate in the study. Dysglycemia&#xD;
      will be defined by the criteria of the Brazilian Society of Diabetes. These individuals will&#xD;
      be divided into four groups: obese with dysglycemia (OBD), obese with normoglycemia (OB),&#xD;
      lean / overweight with dysglycemia (MD) and lean with normoglycemia (M). After the selection&#xD;
      and signing of the informed consent, the patient will be referred for an anthropometric&#xD;
      evaluation, with the measurement of body mass and height, waist circumference and&#xD;
      determination of body fat by the bioimpedance method Biodynamic 450 (BioDynamics , Seattle,&#xD;
      USA). Finally, the 24-hour reminder (R24h) will be applied as a food survey method. And the&#xD;
      dietary calculation will be performed through the AVANUTRIÂ® diet calculation program (Rio de&#xD;
      Janeiro, Brazil). Clinical parameters will include: age, sex, BMI, presence of comorbidities,&#xD;
      use of medications, gastrointestinal complaints, previous surgeries and smoking (absent,&#xD;
      present, prior). Only after approval by the Research Ethics Committee (CEP) of the Pedro&#xD;
      Ernesto University Hospital (HUPE-UERJ), will this recruitment begin.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 5, 2015</start_date>
  <completion_date type="Actual">November 4, 2016</completion_date>
  <primary_completion_date type="Actual">November 4, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation</measure>
    <time_frame>2018</time_frame>
    <description>Study in eutrophic and obese groups with normal glucose tolerance and also obese and eutrophic / overweight with dysglycemia the correlation between serum inflammatory markers, vascular reactivity, degree of hepatic inflammation / fibrosis and intestinal morphology and microbiota.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">47</enrollment>
  <condition>Microbial Colonization</condition>
  <arm_group>
    <arm_group_label>obese plus diabetes,</arm_group_label>
    <description>BMI 30-40kg/m2 and diabetes or pre-diabetes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>obese</arm_group_label>
    <description>BMI 30-40kg/m2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>BMI 20-27,5kg/m2</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Obese patients with dysglycemia or not from the Obesity Clinic from UERJ will be invited to&#xD;
        participate in the study, and individuals with normal or overweight weight with dysglycemia&#xD;
        or not, preferably from the same social class and type of diet of the obese&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men or women between 18 and 50 years old&#xD;
&#xD;
          -  BMI between 30-40kg / m2 with and without diabetes or altered glucose tolerance&#xD;
&#xD;
          -  BMI between 18-24.9 kg / m2 without diabetes or altered glucose tolerance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute disease&#xD;
&#xD;
          -  Chronic pulmonary, cardiovascular, haematological, gastrointestinal, hepatic or renal&#xD;
             diseases;&#xD;
&#xD;
          -  Unstable dietary history, defined as major changes in diet during the previous month&#xD;
             diagnosed by a specialist nutritionist;&#xD;
&#xD;
          -  History of gastrointestinal disturbances in activity or chronic diseases, including -&#xD;
             inflammatory bowel diseases (IBD), chronic diarrhea of unknown etiology, chronic&#xD;
             constipation, disabsorbing syndromes,&#xD;
&#xD;
          -  History of major gastrointestinal tract surgery, except cholecystectomy and&#xD;
             appendectomy;&#xD;
&#xD;
          -  Use of the following medications: probiotics in the last 6 months, systemic&#xD;
             antibiotics, oral corticosteroids, cytokines, methotrexate or cytotoxic&#xD;
             immunosuppressive agents, consumption of large doses of commercial probiotics (greater&#xD;
             than or equal to 10 8 CFU or organisms per day)&#xD;
&#xD;
          -  Positive tests for HIV infection and hepatitis B and C;&#xD;
&#xD;
          -  Pregnant and lactating women;&#xD;
&#xD;
          -  Smokers&#xD;
&#xD;
          -  Chronic alcoholism.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2017</verification_date>
  <study_first_submitted>June 3, 2017</study_first_submitted>
  <study_first_submitted_qc>June 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2017</study_first_posted>
  <last_update_submitted>June 6, 2017</last_update_submitted>
  <last_update_submitted_qc>June 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rio de Janeiro State University</investigator_affiliation>
    <investigator_full_name>Luiz Guilherme Kraemer-Aguiar, MD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

